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Abstract
During systemic inflammation different neutrophil subsets are mobilized to the peripheral blood. These neutrophil subsets
can be distinguished from normal circulating neutrophils (CD16bright/CD62Lbright), based on either an immature CD16dim/
CD62Lbright or a CD16bright/CD62Ldim phenotype. Interestingly, the latter neutrophil subset is known to suppress lymphocyte
proliferation ex vivo, but how neutrophils become suppressive is unknown. We performed transcriptome analysis on the
different neutrophil subsets to identify changes in mRNA expression that are relevant for their functions. Neutrophil subsets
were isolated by fluorescence-activated cell sorting from blood of healthy volunteers that were administered a single dose
of lipopolysaccharide (2 ng/kg i.v.) and the transcriptome was determined by microarray analysis. Interestingly, the
CD16bright/CD62Ldim suppressive neutrophils showed an interferon-induced transcriptome profile. More importantly, IFN-c,
but not IFN-a or IFN-b stimulated neutrophils, acquired the capacity to suppress lymphocyte proliferation through the
expression of programmed death ligand 1 (PD-L1). These data demonstrate that IFN-c-induced expression of PD-L1 on
neutrophils enables suppression of lymphocyte proliferation. Specific stimulation of neutrophils present at the inflammatory
sites might therefore have a pivotal role in regulating lymphocyte-mediated inflammation and autoimmune disease.
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Introduction
Neutrophils represent the highest proportion of circulating
leukocytes in the peripheral blood. Following invasion of
microorganisms, these cells are recruited to the site of infection
where they use their antimicrobial capacity to clear invading
pathogens [1]. In the last decade, this ‘‘conventional’’ view of
neutrophils in the immune response has changed substantially.
Besides their capacity to kill invading pathogens, neutrophils have
been shown to modulate the immune system on various levels [2].
The first evidence that neutrophils can modulate the response of
other immune cells was found in their interaction with dendritic
cells (DCs). Neutrophils were shown to induce maturation of
monocyte-derived DCs and boost DC cytokine production,
resulting in T-cell proliferation and polarization towards a Th1
phenotype [3,4].
Recent studies have shown that during experimental human
endotoxemia i.e. systemic inflammation elicited by LPS adminis-
tration in healthy volunteers or severe trauma changes the
heterogeneity of the circulating neutrophils pool dramatically
[5,6]. Three different neutrophil subsets can be distinguished
based on their expression of CD16 and CD62L. CD16dim/
CD62Lbright neutrophils appear to be released from the bone
marrow and are characterized by a banded nuclear morphology
and immature antimicrobial capacity. CD16bright/CD62Ldim
neutrophils display a hypersegmented nucleus, increased function-
al antimicrobial capacity and, strikingly, exhibit the capacity to
suppress lymphocyte proliferation. This novel immune regulatory
mechanism for neutrophils was shown to be dependent on
hydrogen peroxide release and expression of integrin MAC-1
(aMb2) [6]. To date, it is unclear how this CD16
bright/CD62Ldim
subset of neutrophils acquires the ability to suppress lymphocyte
proliferation. Knowledge on the regulation of this process could
have important implications in the modulation of lymphocyte-
mediated disease pathology.
Previously, we have shown that the total pool of circulating
neutrophils during experimental human endotoxemia has a
specific transcriptome profile that was reminiscent to a profile
induced by a combination of direct activation by inflammatory
cytokines and the influx of young neutrophils from the bone
marrow [7]. In the current study, we further investigated the
transcriptome of the different neutrophil subsets that emerge in the
circulation during experimental human endotoxemia, based on
the expression of CD16 and CD62L in order to identify factors
involved in generation of suppressive neutrophils. Additionally, we
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explored the mechanisms behind IFN-c-induced neutrophil-
mediated lymphocyte suppression.
Materials and Methods
Subjects and experimental human endotoxemia model
The neutrophil subset transcriptome was studied in 4 healthy
male volunteers who participated in a human endotoxemia trial
(Clinical Trial Register number NCT01374711, placebo group).
The study protocol was approved by the Ethics Committee of the
Radboud University Medical Centre and complies with the
Declaration of Helsinki including current revisions and the Good
Clinical Practice guidelines. Written informed consent was
obtained from all study participants.
The experiments were performed according to a strict clinical
protocol as described previously [8]. Subjects were screened before
the start of the experiment and had a normal physical
examination, electrocardiography, and routine laboratory values
(including serology on HIV and hepatitis B). Subjects with febrile
illness during the two weeks before the experiment were excluded.
Subjects were not allowed to take any prescription drugs and asked
to refrain from caffeine and alcohol intake 24 hours before the
start of the experiment. Furthermore, subjects refrained from food
12 hours before the start of each endotoxemia experiment. After
admission to the research intensive care unit of the Radboud
University Nijmegen Medical Centre, purified LPS (US Standard
Reference Endotoxin Escherichia Coli O:113) obtained from the
Pharmaceutical Development Section of the National Institutes of
Health (Bethesda, MD) was administered at a dose of 2 ng/kg
body weight. In all subjects, heart rate (5-lead electrocardiogram)
and blood pressure (20-gauge radial artery catheter) were
monitored starting 2 hours before administration of LPS until
discharge 8 hours after LPS administration. A cannula was placed
in an antecubital vein to permit infusion of prehydration fluid (1.5
L 2.5% glucose/0.45% saline 1 hour before LPS administration),
endotoxin, and continuous infusion of 2.5% glucose/0.45% saline
(150 mL/hour during 8 hours after LPS administration) to ensure
optimal hydration status. Body temperature was measured using
an infrared tympanic thermometer (FirstTemp Genius, Sherwood
Medical, Crawley/Sussex, UK). The course of endotoxin-induced
flu-like symptoms (headache, nausea, shivering, and muscle and
back pain) was scored every 30 minutes on a 6-point Likert scale
(0 = no symptoms, 5 = very severe symptoms), resulting in a total
score of 0 to 25.
FACS analysis
During human endotoxemia experiments, sodium heparin
anticoagulated blood was drawn from the arterial line. Erythro-
cytes were lysed in isotonic ice-cold NH4Cl solution (8.3 g/L
NH4Cl, 1 g/L KHCO3 and 37 mg/L EDTA) followed by
centrifugation at 4uC. Total leukocytes were washed with PBS and
stained with aCD62L, aCD16 and aCD14 (BD Biosciences) for
30 minutes at 4uC. Subsequently, the cells were washed and sorted
on the FACSAria II (BD Biosciences). Sorted cell fractions were
washed with PBS and dissolved in RLT lysis buffer containing 1%
b-mercaptoethanol and immediately frozen at 280u.
RNA isolation and microarray analysis
RNA was isolated by Qiagen RNAeasy RNA isolation kit
according to the manufacturer’s protocol. In addition, DNA
contamination was removed by on column DNase treatment
(Qiagen). Total RNA yield was determined on the nanodrop ND-
1000 (Isogen life sciences), and total RNA quality was assessed by
the use of RNA 6000 Nano chips on the Agilent 2100 bioanalyzer
(Agilent). Neutrophil gene expression was measured on Affymetrix
Human ST 1.0 exon arrays. RNA material was first amplified,
transformed to cDNA and labeled using ambion WT expression
kit and the Affymetrix terminal labeling kit. Labeled cDNA was
then hybridized for 17 hours at 42uC to a Human ST 1.0 exon
array, washed and stained according to manufacturers’ instruc-
tions and scanned on a Genechip scanner 3000 (Affymetrix).
Microarray data has been made available to the Gene expression
omnibus (GEO) with accession number GSE42358.
Affymetrix CEL-files from microarray scans were uploaded in
the exon array analyzer tool [9]. After quality control, this tool
uses Robust Multiarray Averaging (RMA) analysis for normaliza-
tion of intensity values and a LIMA statistical analysis for large
data sets to determine statistically significant differentially
expressed genes in the different groups. The experiment groups
at t = 4 hours after LPS were either compared relative to t = 0
hours or compared mutually.
Neutrophil and PBMC isolation
After written informed consent, blood was drawn from healthy
donors in EDTA anticoagulation tubes. Blood was diluted 2:1 with
PBS. Mononuclear cells and granulocytes were separated by
centrifugation using Ficoll-Paque. Erythrocytes were lysed in
isotonic ice-cold NH4Cl solution (8.3 g/L NH4Cl, 1 g/L KHCO3
and 37 mg/L EDTA) followed by centrifugation at 4uC as
described previously [10]. After isolation, granulocytes (.95%
pure with eosinophils as major contaminant) were washed in PBS
and resuspended in HEPES buffered RPMI 1640 supplemented
with 10% FCS. After Ficoll-Paque centrifugation, PBMCs fraction
was washed twice with PBS and resuspended in RPMI supple-
mented with 2 mM L-Glutamine and 10% heat-inactivated
human serum.
CD274, CD273 and CD279 expression experiments
Neutrophils were suspended in HEPES-buffered RPMI supple-
mented with 10% FCS to a concentration of 5.106/mL and
stimulated with 100 ng/mL TNF-a (BD Biosciences), 50 ng/mL
G-CSF (R&D systems), 50 ng/mL GM-CSF (Sanquin), 200 ng/
mL IFN-a2 (Roche), 100 U/mL IFN-b1A (Invitrogen), 1 to 1000
ng/mL IFN-c (Sigma), 50 ng/mL LPS (Invitrogen) for 18–20
hours at 37uC+5% CO2. For short IFN-c exposure, neutrophils
were stimulated 15 minutes or 2 hours, where after IFN-c was
washed away and neutrophils were further incubated in HEPES-
buffered RPMI supplemented with 10% FCS till 18–20 hours at
37uC+5% CO2. For kinetic experiments, neutrophils were
stimulated 0, 2, 4, 6, 8 or 20 hours. Neutrophils were washed
once and stained for aCD274, aCD273 or aCD279 (BD
Biosciences) for 30 minutes at 4uC. Expression of CD274,
CD273 and CD279 were analyzed using a flow cytometer
(FACSCalibur or FACS LSR II, BD Biosciences).
For CD274 mRNA expression analysis, neutrophils were
stimulated 0, 2, 4, 6 and 24 hours with IFN-c, washed once with
PBS and dissolved in RLT lysis buffer containing 1% b-
mercaptoethanol and immediately frozen at 280u.
Neutrophil survival
Neutrophils were suspended in HEPES-buffered RPMI supple-
mented with 10% FCS to a concentration of 5.106/mL and
stimulated with 100 ng/mL TNF-a (BD Biosciences), 50 ng/mL
G-CSF (R&D systems), 50 ng/mL GM-CSF (Sanquin), 200 ng/
mL IFN-a2 (Roche), 100 U/mL IFN-b1A (Invitrogen), 100 ng/
mL IFN-c (Sigma), 50 ng/mL LPS (Invitrogen) for 18–20 hours at
37uC+5% CO2. Apoptosis was determined by annexin-V binding
(BD Biosciences). After staining the cells with annexin-V for
PD-L1 on Neutrophils Mediate Immune Suppression
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15 min in the dark at room temperature in annexin-binding
buffer, 10 mM HEPES (pH 7.4), 140 mM NaCl, 2.5 mM CaCl2,
7-AAD were added. Cells were analyzed using a flow cytometer
(FACSCalibur or FACS LSR II, BD Biosciences).
Lymphocyte proliferation assay
Neutrophils were suspended in HEPES-buffered RPMI supple-
mented with 10% FCS to a concentration of 5.106/mL and
stimulated with either recombinant 50 ng/mL GM-CSF, 200 ng/
mL IFN-a2 (Roche), 100 U/mL IFN-b1A (Invitrogen), 100 ng/
mL IFN-c (Sigma) or left untreated for 18–20 hours at 37uC+5%
CO2. PBMCs from same donor were loaded with 5 mM CFSE
(Sigma) and incubated 18–20 hours in HEPES-buffered RPMI
supplemented with 10% pooled human AB-serum (Sigma) at
37uC+5% CO2. Neutrophils were washed twice with PBS,
resuspended in HEPES-buffered RPMI supplemented with 10%
pooled human AB-serum (Sigma) and added in various ratios to
the CFSE-loaded PBMCs. Proliferation was stimulated with 5 mg/
mL PHA (Sigma), CD3 (0.15 mg/mL)/CD28 (1 mg/mL) (Sanquin)
or heat-killed Candida albicans (1.106 CFU/mL) and measured by
flow cytometry after 3 (PHA and CD3/CD28) or 7 days (C.
albicans) with the gating strategy as described in supplemental
figure S3. Blocking studies were performed with 10 mg/mL
aCD274 (clone MIH1, eBiosciences), 10 mg/mL aCD11b (clone
44a, gift Prof. Leo Koenderman) or 10 mg/mL aPAFr (clone
11A4, Cayman Chemicals) as isotype control that were present
throughout the 3 days incubation.
Neutrophil-PBMC interaction
Neutrophils were suspended in HEPES-buffered RPMI supple-
mented with 10% FCS to a concentration of 5.106/mL and
stimulated with IFN-c (Sigma) or left untreated for 18–20 hours at
37uC+5% CO2, washed once with PBS and loaded with 5 mM
Calcein-Blue (Invitrogen) in PBS supplemented with 0.1% BSA
after which the neutrophils were washed twice with PBS and
suspended to a concentration of 4.106/mL in RPMI supplemented
with 2 mM L-Glutamine and 10% heat-inactivated human serum.
PBMCs from the same donor were incubated 18–20 hours at
37uC+5% CO2, washed once with PBS and loaded with 1 mM
Calcein-AM (Sigma) in PBS supplemented with 0.1% BSA after
which the PBMCs were washed twice with PBS and suspended to
a concentration of 2.106/mL in RPMI supplemented with 2 mM
L-Glutamine and 10% heat-inactivated human serum. Neutro-
phils and PBMC were mixed 2:1, stimulated with 5 mg/mL PHA
(Sigma) in the presence or absence of 10 mg/mL aCD11b (clone
44a) blocking antibody and Calcein-Blue and Calcein-AM double
positive events were measured by flow cytometry (FACSCalibur or
FACS LSR II, BD Biosciences).
Statistics
Statistical analysis was performed by using Graphpad prism 5.
Reported values are shown as mean with standard error of the
mean (SEM). We used a t-test, one-way ANOVA with Tukey post
hoc test or two-way ANOVA with Bonferoni multiple compari-
sons. P values of ,0.05 were considered statistically significant.
Results
Neutrophil subsets mobilized during experimental
human endotoxemia display distinctive transcriptome
profiles
Experimental human endotoxemia was used to induce systemic
inflammation for mobilization of different neutrophil subsets into
the circulation. Granulocytes were gated (Gating strategy
described in supplemental figure S1) based on FSC/SSC, negative
for CD14, and showed a large population of CD16bright/
CD62Lbright neutrophils, a small population of CD16bright/
CD62Ldim neutrophils and CD16negative/CD62Lhigh eosionophils
(Figure 1A, upper panel). Four hours after a single intravenous
dose of LPS (2 ng/kg body weight), 3 neutrophil subsets could be
easily identified based on their expression of CD16 and CD62L
(Figure 1A, lower panel). Hereafter, the different neutrophil
phenotypes were isolated by FACS [5]. These subsets represented
on average a CD16bright/CD62Lbright (62%), a CD16dim/
CD62Lbright (19%) and a CD16bright/CD62Ldim (19%) phenotype
(Figure 1B). Microarray analysis of these neutrophil subsets
revealed a clear response to LPS administration with 819
(CD16bright/CD62Lbright), 998 (CD16bright/CD62Ldim) and 1108
(CD16dim/CD62Lbright) genes differentially expressed at least 2-
fold relative to neutrophils isolated prior to LPS administration
(Table S1). A total number of 690 genes were persistently higher
expressed throughout the neutrophil subsets with lowest expression
in CD16dim/CD62Lbright, intermediate expression in CD16bright/
CD62Lbright and highest expression in CD16bright/CD62Ldim
neutrophils. Gene ontology (GO)-term enrichment analysis of this
set of genes showed overrepresentation of genes involved in
regulation of immune responses and apoptosis, but also the
regulation of leukocyte proliferation (Figure 1C). The top 50 genes
increased in CD16bright/CD62Ldim neutrophils compared to
normal CD16bright/CD62Lbright neutrophils were enriched for
interferon signaling, which included increased expression of
CXCL10, IDO1, IL1A, CCRL2 and CD274 (Figure 1D). Interest-
ingly, from this list, expression of CD274 (the gene encoding for
Programmed Death-Ligand 1, PD-L1), was highly increased in the
suppressive CD16bright/CD62Ldim neutrophils compared to the
CD16bright/CD62Lbright and CD16dim/CD62Lbright neutrophils.
PD-L1 is a surface expressed ligand known to interact with its
receptor PD-1 on various cell types to suppress cellular responses
and proliferation [11]. We measured PD-L1 surface expression on
the different neutrophil subsets 4 and 6 hours post-endotoxin
administration. The surface protein expression of PD-L1 was
significantly higher on CD16bright/CD62Ldim neutrophils com-
pared to CD16dim/CD62Lbright neutrophils, and intermediate on
CD16bright/CD62Lbright neutrophils (Figure 1E).
Ex vivo stimulation of neutrophils with IFN-c induces
expression of PD-L1
With regard to the pronounced IFN-induced profile in
CD16bright/CD62Ldim neutrophils, we further investigated the
role of IFN signaling in the generation of suppressive neutrophils
by stimulating freshly isolated neutrophils with various cytokines
or LPS. Interestingly, especially IFN-c, and to a lesser extend IFN-
a or IFN-b, but not G-CSF, GM-CSF, TNF-a, LPS, increased
PD-L1 expression as measured by flow cytometry (Figure 2A, and
representative histograms in supplemental figure S2). Expression
of PD-L1 could not be directly related to increased survival of the
neutrophils by IFN-c, since GM-CSF and G-CSF did not increase
expression of PD-L1, but did increase survival (Figure 2B).
Subsequently, we assessed the dynamics of PD-L1 expression on
IFN-c-stimulated neutrophils. Expression of PD-L1 was especially
apparent on annexin-V negative neutrophils (Figure 2C). Treat-
ment with 1 ng/ml IFN-c was sufficient to induce PD-L1
expression, reaching a plateau at 10–100 ng/ml (Figure 2D).
Stimulation of neutrophils with IFN-c for only 15 minutes was
sufficient to induce PD-L1 expression after 18–20 hours
(Figure 2E). Stimulation of neutrophils with IFN-c increased
CD274 mRNA expression starting at 2 hours, and reached
PD-L1 on Neutrophils Mediate Immune Suppression
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maximum after 6 hours (Figure 2F). Subsequently, we determined
expression of PD-L1 on neutrophils in time. Stimulation of
neutrophils with IFN-c-induced PD-L1 surface expression slightly
after 6 hours, which increased after 8 and 20 hours (Figure 2G),
whereas this was not detected for CD273 (PD-L2) (Figure 2H) or
CD279 (PD-1) (Figure 2I).
IFN-c-stimulated neutrophils suppress lymphocyte
proliferation
We determined the capacity of neutrophils that were stimulated
with different types of interferons or GM-CSF to suppress
lymphocyte proliferation (Gating strategy described in supplemen-
tal figure S3). Untreated, GM-CSF-, IFN-a- and IFN-b-stimulated
neutrophils showed modest suppression of phytohemagglutinin
(PHA)-induced lymphocyte proliferation, whereas IFN-c-stimulat-
ed neutrophils showed a robust, up to 70%, inhibition of
proliferation (Figure 3A–B and supplemental figure S3). Suppres-
sion of proliferation was also observed when lymphocytes were
activated by CD3/CD28 (Figure 3C) or Candida albicans
(Figure 3D), which points toward a general mechanism of
suppression. To exclude a role for other leukocytes such as
monocytes or eosinophils in the suppression of lymphocyte
proliferation, neutrophils (CD16positive, CD14negative, CD3negative)
and lymphocytes (CD16negative, CD14negative, CD3positive) were
sorted by FACS. IFN-c-stimulated purified neutrophils showed
increased capacity to suppress PHA-induced purified lymphocyte
proliferation compared to untreated neutrophils (Figure 3E).
Although the induction of PHA-induced proliferation was
decreased (data not shown), the level of suppression was
comparable with total cell populations, indicating that this process
is not dependent on the presence of other cell types such as
monocytes.
Figure 1. Microarray analysis of neutrophils subsets during human experimental endotoxemia. (A) Flow cytometry dot plot of
neutrophils prior to, and 4 hours after in vivo LPS administration. The fluorescence signal for CD16 is displayed on the x-axis and the fluorescence
signal for CD62L is displayed on the y-axis. At t = 0 hours (upper panel) a large population of CD16bright/CD62Lbright neutrophils, a small population of
CD16high/CD62Ldim neutrophils and a population of CD16negative cells representing eosinophils is present. At t = 4 hours after LPS (lower panel),
neutrophil with CD16dim/CD62Lbright and CD16dim/CD62Ldim subsets appeared and these were FACS sorted for microarray analysis. (B) Absolute cell
numbers of different neutrophil subsets in the blood at 0 and 4 hours after LPS challenge (n = 6). Data are expressed as means 6 SEM. (C)
Overrepresented functional categories in CD16high/CD62Ldim neutrophils based on the total list of differentially expressed genes relative to prior to
LPS. A minimum of 5 genes and a p value of 0,01 were taken as cutoff. All significantly overrepresented categories are shown. The 4 highest parent
levels of the Gene ontology tree were excluded for this graph since various general processes are involved in these. (D) Network of several interferon-
induced genes that are upregulated in CD16high/CD62Ldim neutrophils after intravenous administration of LPS. The color intensity of the nodes
indicates the level of upregulation. (E) Expression of CD274 on isolated neutrophil subsets from volunteers intravenous administered LPS at 4 and 6
hours after LPS. *P,0.05. Data are expressed as means 6 SEM (n= 4).
doi:10.1371/journal.pone.0072249.g001
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Subsequently, lymphocyte phenotype after co-culture with
neutrophils was analyzed. There was no significant difference in
the distribution of CD4 and CD8 lymphocytes after co-stimulation
with either IFN-c-stimulated or control neutrophils (Figure 3F).
IFN-c-induced PBMC suppression is dependent on cell-
cell contact and PD-L1
Next, we investigated whether neutrophil-mediated T-cell
suppression was dependent on cell-cell contact between lympho-
Figure 2. PD-L1 expression on IFN-c treated neutrophils. (A) Neutrophils were stimulated 18–20 hours with different cytokines and growth
factors and CD274 mean fluorescence intensity (MFI) was measured. (B) Neutrophil survival after 18–20 hours stimulation with different cytokines and
growth factors shown on the x-axis and the percentage of cells that were positive for either Annexin-V, 7-AAD or both on the y-axis. (C) Freshly
isolated neutrophils were stimulated 18–20 hours with IFN-c or GM-CSF and CD274 mean fluorescence intensity (MFI) was measured on annexin-V
negative and annexin-V positive neutrophils (D) Neutrophils were stimulated 18–20 hours with different concentrations of IFN-c and CD274 mean
fluorescence intensity (MFI) was measured. (E) Neutrophils were stimulated with 100 ng/ml IFN-c and incubated for different periods before washing
and further incubation till 18–20 hours and CD274 mean fluorescence intensity (MFI) was measured. (F) Gene expression of CD274 in IFN-c stimulated
neutrophils. Expression is shown in time with the use of GAPDH as reference gene. Surface expression of (G) CD274, (H) CD273 and (I) CD279 after 0,
2, 4, 6, 8 and 20 hours stimulation with IFN-c. *P,0.05, **P,0.01, ***P,0.001. Data are expressed as means 6 SEM (n= 4).
doi:10.1371/journal.pone.0072249.g002
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cytes and IFN-c-stimulated neutrophils using a transwell system
separating both cell suspensions. In this system, neutrophils lost
their suppressive capacity indicating that cellular proximity is
needed between neutrophils and lymphocytes (Figure 4A).
Previously it was postulated that CD16bright/CD62Ldim neutro-
phils form a synapse with lymphocytes wherein integrin MAC-1
(CD11b) plays a pivotal role [6]. We hypothesized that, next to the
formation of a synapse by integrin MAC-1 on neutrophils,
expression of PD-L1 would contribute to the suppressive function
on lymphocyte proliferation because expression of this molecule
on other cell types enables suppression of lymphocyte activation
and proliferation [11]. Blocking MAC-1 using monoclonal
antibody 44a in our co-cultures showed a modest decrease in
suppressive capacity (Figure 4B). As hypothesized, PD-L1 showed
to be absolutely essential for the IFN-c-induced suppressive effect,
because blocking PD-L1 attenuated suppression to the level of
unstimulated neutrophils, whereas the isotype control antibody
showed no effect (Figure 4B). In order to evaluate the role of
MAC-1 and IFN-c on the interaction between neutrophils and
lymphocytes, we loaded neutrophils with Calcein-Blue and
PBMCs with Calcein-AM. Interactions between these cell types
were visualized as double positive events by flow cytometry. The
percentage double positive events increased to more than 20% in
120 minutes of co-culture, which decreased to 15% in the
presence of aCD11b (Figure 4C). However, no differences were
found between IFN-c-, GM-CSF-stimulated or unstimulated
neutrophils. Therefore, we conclude that interactions between
neutrophils and lymphocytes occur independently of stimulation,
but only in the presence of PD-L1 expression neutrophils inhibit
lymphocyte proliferation.
Discussion
In the present study, we show that the neutrophil subsets that
appear in the circulation during systemic inflammation elicited by
experimental human endotoxemia, have distinct gene expression
profiles. Our gene expression data indicate that for a significant
amount of genes, the expression increases on a gradual scale with
lowest expression in CD16dim/CD62Lbright neutrophils, intermedi-
ate expression in CD16bright/CD62Lbright neutrophils and the
Figure 3. IFN-c stimulated neutrophils suppress T-cell proliferation. (A) Neutrophils stimulated 18–20 hours with either GM-CSF or IFN-c or
left untreated and inhibition of PHA-induced PBMC proliferation was measured after 3 days. (B) Neutrophils stimulated 18–20 hours with IFN-a, IFN-b,
IFN-c or left untreated and inhibition of PHA-induced PBMC proliferation was measured after 3 days. (C) Neutrophils stimulated 18–20 hours with IFN-
c or left untreated and inhibition of CD3/CD28-induced PBMC proliferation was measured after 3 days. (D) Neutrophils stimulated 18–20 hours with
IFN-c or left untreated and inhibition of Candida albicans-induced proliferation was measured after 7 days. (E) CD16positive CD14negative CD3negative
sorted neutrophils were stimulated 18–20 hours with IFN-c or left untreated and inhibition of PHA-induced CD3positive CD14negative CD16negative sorted
lymphocyte proliferation was measured after 3 days. (F) Percentage of CD4 and CD8 lymphocytes after 3 days PHA-induced PBMC proliferation in the
presence of neutrophils stimulated 18–20 hours with IFN-c or left untreated.
doi:10.1371/journal.pone.0072249.g003
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highest expression in CD16bright/CD62Ldim neutrophils. With
regard to their pronounced inflammatory gene expression pattern
and hypersegmented nucleus, it can be suggested that CD16bright/
CD62Ldim neutrophils are representative of a later phase in the
lifespan of neutrophils. The origin of these CD16bright/CD62Ldim
neutrophils is currently unknown. Since CD62L is shed from
activated neutrophils, this marker has limitations in defining a
homogenous subset of neutrophils [12]. The CD16bright/CD62Ldim
neutrophil subset, obtained during experimental human endotox-
emia, is clearly able to suppress lymphocyte proliferation in contrast
to the CD16dim/CD62Ldim neutrophils [6].
We sought to investigate the factors involved in the generation
of CD16bright/CD62Ldim suppressive neutrophil subset during
systemic inflammation in vivo based on their transcriptome. Our
gene expression data showed upregulation of various IFN-induced
genes during endotoxemia, which was most pronounced in the
CD16bright/CD62Ldim neutrophil subset. Previously, it has been
shown that stimulation of whole blood with IFN-c + GM-CSF
induces expression of IFN-regulated genes CXCL10, IDO1, IL1A,
CCRL2 and CD274 [13], a profile that resembles the transcriptome
of CD16bright/CD62Ldim neutrophils.
The moment of increased surface expression of PD-L1 on
neutrophils during experimental human endotoxemia (6 hours
post LPS), compared to our ex vivo experiments (6–8 hours post
IFN-c), which suggests that neutrophils are exposed to IFN-c
shortly after LPS infusion. The main producers of IFN-c are
CD4+ Th1 lymphocytes, CD8+ cytotoxic lymphocytes and
natural killer (NK) cells [14]. These cell types typically do not
respond directly to LPS, therefore, an indirect effect of LPS on the
release of IFN-c appears more likely. For instance, it was recently
shown that flagellin-induced rapid IL-18 release from dendritic
cells, which induced IFN-c release from memory CD8+ T cells
within 2 hours [15]. However, whether a similar indirect
mechanism is responsible for IFN-c release after LPS administra-
tion remains to be determined. Currently, we have no evidence
that IFN-c induces PD-L1 expression on neutrophils in vivo, or
whether PD-L1 on CD16bright/CD62Ldim neutrophils is essential
for the suppressive capacity observed by Pillay and co-workers [6].
The data we present here do support an important role for PD-L1
on neutrophils in lymphocyte proliferation in vitro.
The induction of PD-L1 on IFN-c-stimulated neutrophils is
likely de novo synthesis since a recent study did not detect this
protein in the granules [16]. Expression of PD-L1 on circulating
neutrophils has been shown in patients with active tuberculosis
[17]. This is especially interesting because neutrophils from
patients with active tuberculosis also exhibit an IFN-induced
transcriptome profile, including increased expression of CXCL10
and CD274 [18]. To date, no studies have investigated PD-L1
expression on neutrophils during systemic inflammatory diseases.
Interestingly, during sepsis, increased expression of PD-L1 on
monocytes has been suggested to play an important role in sepsis-
induced immunosuppression [19,20].
To our knowledge, we are the first to identify an immune-
suppressive effect of IFN-c through expression of PD-L1 on
neutrophils. Although originally defined as an agent with direct
antiviral activity, the properties of IFN-c also include regulation of
several neutrophil functions such as stimulation of the respiratory
burst [21], increased ex vivo survival [22] and antigen presentation
[23]. We demonstrate that the IFN-c-induced suppression of
lymphocyte proliferation is dependent on increased expression of
PD-L1. Under steady state conditions, expression of PD-L1 on
neutrophils is very low [23] and these neutrophils show only a
minor suppressive phenotype ex vivo. The suppressive phenotype
on lymphocyte proliferation was independent of the stimulation
method, as similar findings were observed for PHA, CD3/CD28
and Candida albicans stimulation. The suppressive capacity of the
IFN-c-stimulated neutrophils, as shown by neutrophil lymphocyte
co-culture in transwell experiments, occurred in a cell-cell contact
dependent manner. IFN-c has been shown to increase expression
of PD-L1 on various cell types [24] resulting in suppressive activity
through ligation with PD-1 on target cells [25]. By blocking PD-L1
on neutrophils we verified that suppression of lymphocyte
proliferation was dependent on PD-L1 – PD1 signaling.
This study shows for the first time that suppressive neutrophils
can be generated using IFN-c, which could be used as a novel
approach to modulate inflammation. For instance, during
influenza infections, the tissue damage that is associated with
Figure 4. Suppression of T-cell proliferation by IFN-c stimulated neutrophils is dependent on cell-cell contact and PD-L1. (A)
Neutrophils stimulated with IFN-c or left untreated for 18–20 hours and PHA-stimulated PBMCs were co-cultured for 3 days in separate
compartments by the use of cell culture inserts. Percentage of inhibition of PHA-induced proliferation was calculated. (B) Neutrophils stimulated 18–
20 hours with IFN-c or left untreated and inhibition of PHA-induced PBMC proliferation in the presence of aCD11b, aCD274 or aPAFr was measured
after 3 days. (C) Neutrophils stimulated 18–20 hours with either GM-CSF or IFN-c or left untreated and interactions between Calcein-blue labeled
neutrophils with Calcein-AM labeled PBMCs after 120 minutes of co-culture measured by flow cytometer. Ratios indicate neutrophils: lymphocytes
(Figure A–E). *P,0.05, **P,0.01, ***P,0.001. Data are expressed as means 6 SEM (n= 4).
doi:10.1371/journal.pone.0072249.g004
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disease pathology is dependent on the presence of T-cells [26]. In
this case, more damage is caused by the host’s inflammatory
response compared with damage caused by the virus itself. In
order to maintain balance in inflammatory responses and to
prevent excessive tissue damage, other immune cells such as
dendritic cells and macrophages, but as suggested by our data also
neutrophils, dampen excessive T-cell responses. This hypothesis is
supported by the fact that neutrophil depletion in influenza-
infected mice leads to aggravated disease characterized by rapid
weight loss, pneumoniae and death [27,28].
In conclusion, stimulation of peripheral blood neutrophils with
IFN-c ex vivo induces PD-L1 expression on neutrophils, which is
shown to be essential in the suppression of lymphocyte prolifer-
ation in vitro. Therefore, IFN-c-stimulated neutrophils might
provide a novel therapeutic option for the reduction of T-cell
mediated tissue damage in inflammatory diseases.
Supporting Information
Figure S1 FACS gating strategy of sorted neutrophil
subsets. Whole blood was shocked and labeled with antibodies.
First, granulocytes were gated based on forward/sideward scatter
(upper panels). Then CD14- granulocytes were selected (mid
panels). Then neutrophil subsets were selected based on CD16 and
CD62L expression (lower panels).
(PDF)
Figure S2 Neutrophil CD274 expression gating strategy.
(A) Neutrophils were selected on the basis of their FSC/SSC. (B)
MFI of the whole granulocyte population was determined. (C)
Overlay of PD-L1 expression of unstimulated, IFNa, IFNband
IFNc-stimulated neutrophils.
(PDF)
Figure S3 Lymphocyte proliferation assay gating strat-
egy. (A) Lymphocytes were selected on the basis of their FSC/
SSC. (B) FITC-positive events were selected based on the PHA-
stimulated lymphocytes to exclude inclusion of apoptotic neutro-
phils. (C) The gate % proliferation was selected based on the
unstimulated lymphocytes. All gates were identical in all samples
within one experiment.
(PDF)
Table S1 Microarray analysis of neutrophil subsets. Genes
differentially expressed at least 2-fold relative to neutrophils
isolated prior to LPS administration are depicted.
(PDF)
Acknowledgments
The authors would like to thank Rebecca Koch, Lucas van Eijk and Tijn
Bouw for performing the human endotoxemia studies. We furthermore
thank all the volunteers that participated in these studies.
Author Contributions
Conceived and designed the experiments: JDL SdK. Performed the
experiments: JDL JL SdK. Analyzed the data: JDL SdK. Contributed
reagents/materials/analysis tools: JL MK MN PP LK. Wrote the paper:
SdK JDL GF PP PH.
References
1. Borregaard N (2010) Neutrophils, from marrow to microbes. Immunity 33: 657–
670.
2. Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011) Neutrophils in the
activation and regulation of innate and adaptive immunity. Nat Rev Immunol
11: 519–531.
3. van Gisbergen KP, Ludwig IS, Geijtenbeek TB, van Kooyk Y (2005)
Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact between
dendritic cells and neutrophils. FEBS Lett 579: 6159–6168.
4. Megiovanni AM, Sanchez F, Robledo-Sarmiento M, Morel C, Gluckman JC, et
al. (2006) Polymorphonuclear neutrophils deliver activation signals and antigenic
molecules to dendritic cells: a new link between leukocytes upstream of T
lymphocytes. J Leukoc Biol 79: 977–988.
5. Pillay J, Ramakers BP, Kamp VM, Loi AL, Lam SW, et al. (2010) Functional
heterogeneity and differential priming of circulating neutrophils in human
experimental endotoxemia. JLeukocBiol 88: 211–220.
6. Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, et al. (2012) A subset of
neutrophils in human systemic inflammation inhibits T cell responses through
Mac-1. J Clin Invest 122: 327–336.
7. de Kleijn S, Kox M, Sama IE, Pillay J, van Diepen A, et al. (2012)
Transcriptome kinetics of circulating neutrophils during human experimental
endotoxemia. PLoS One 7: e38255.
8. Leentjens J, Kox M, Koch RM, Preijers F, Joosten LA, et al. (2012) Reversal of
Immunoparalysis in Humans In Vivo: A Double-Blind, Placebo-controlled,
Randomized Pilot Study. Am J Respir Crit Care Med 186: 838–845.
9. Gellert P, Uchida S, Braun T (2009) Exon Array Analyzer: a web interface for
Affymetrix exon array analysis. Bioinformatics 25: 3323–3324.
10. Langereis JD, Franciosi L, Ulfman LH, Koenderman L (2011) GM-CSF and
TNFalpha modulate protein expression of human neutrophils visualized by
fluorescence two-dimensional difference gel electrophoresis. Cytokine 56: 422–
429.
11. Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in
tolerance and immunity. Annu Rev Immunol 26: 677–704.
12. Hayashi F, Means TK, Luster AD (2003) Toll-like receptors stimulate human
neutrophil function. Blood 102: 2660–2669.
13. Kotz KT, Xiao W, Miller-Graziano C, Qian WJ, Russom A, et al. (2010)
Clinical microfluidics for neutrophil genomics and proteomics. NatMed 16:
1042–1047.
14. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to
interferon-gamma. Annu Rev Immunol 15: 749–795.
15. Kupz A, Guarda G, Gebhardt T, Sander LE, Short KR, et al. (2012) NLRC4
inflammasomes in dendritic cells regulate noncognate effector function by
memory CD8(+) T cells. Nat Immunol 13: 162–169.
16. Rorvig S, Ostergaard O, Heegaard NH, Borregaard N (2013) Proteome
profiling of human neutrophil granule subsets, secretory vesicles, and cell
membrane: correlation with transcriptome profiling of neutrophil precursors.
J Leukoc Biol.
17. McNab FW, Berry MP, Graham CM, Bloch SA, Oni T, et al. (2011)
Programmed death ligand 1 is over-expressed by neutrophils in the blood of
patients with active tuberculosis. Eur J Immunol 41: 1941–1947.
18. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An
interferon-inducible neutrophil-driven blood transcriptional signature in human
tuberculosis. Nature 466: 973–977.
19. Zhang Y, Li J, Lou J, Zhou Y, Bo L, et al. (2011) Upregulation of programmed
death-1 on T cells and programmed death ligand-1 on monocytes in septic shock
patients. Crit Care 15: R70.
20. Hotchkiss RS, Opal S (2010) Immunotherapy for sepsis--a new approach against
an ancient foe. NEnglJMed 363: 87–89.
21. Cassatella MA, Bazzoni F, Flynn RM, Dusi S, Trinchieri G, et al. (1990)
Molecular basis of interferon-gamma and lipopolysaccharide enhancement of
phagocyte respiratory burst capability. Studies on the gene expression of several
NADPH oxidase components. J Biol Chem 265: 20241–20246.
22. Yoshimura T, Takahashi M (2007) IFN-gamma-mediated survival enables
human neutrophils to produce MCP-1/CCL2 in response to activation by TLR
ligands. J Immunol 179: 1942–1949.
23. Bankey PE, Banerjee S, Zucchiatti A, De M, Sleem RW, et al. (2010) Cytokine
induced expression of programmed death ligands in human neutrophils.
Immunol Lett 129: 100–107.
24. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, et al. (2008) A critical role of
IFNgamma in priming MSC-mediated suppression of T cell proliferation
through up-regulation of B7-H1. Cell Res 18: 846–857.
25. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, et al. (2000)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family
member leads to negative regulation of lymphocyte activation. J Exp Med 192:
1027–1034.
26. Rygiel TP, Rijkers ES, de Ruiter T, Stolte EH, van der Valk M, et al. (2009)
Lack of CD200 enhances pathological T cell responses during influenza
infection. J Immunol 183: 1990–1996.
27. Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, et al. (2009)
Neutrophils ameliorate lung injury and the development of severe disease during
influenza infection. J Immunol 183: 7441–7450.
28. Fujisawa H (2008) Neutrophils play an essential role in cooperation with
antibody in both protection against and recovery from pulmonary infection with
influenza virus in mice. J Virol 82: 2772–2783.
PD-L1 on Neutrophils Mediate Immune Suppression
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e72249
